4.26900 EUR
0.613
16.77%
Last update Dec 16, 4:00 PM CET
Market closed
Day range
2.73700
4.26900
Previous close
3.65600
Open
2.73700
Access this stock data via API
Subscribe
Aldeyra Therapeutics Inc.
4.27
0.61
16.77%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 4.6M 7.2M 6.3M 12.5M
Selling general and admin 2.2M 1.4M 2.6M 1.7M
Other operating expenses
Operating income -6.8M -8.7M -8.9M -14.1M
Non operating interest income
Income 672.2K 743.2K 836.5K 1.1M
Expense 405.6K 401.1K 412.1K 401.3K
Other income expense
Pretax income -6.6M -8.3M -8.5M -13.5M
Tax provision
Net income -6.6M -8.3M -8.5M -13.5M
Basic EPS -0.1 -0.2 -0.2
Diluted EPS -0.1 -0.2 -0.2
Basic average shares 51.2M 51.2M 51.0M
Diluted average shares 51.2M 51.2M 51.0M
EBITDA -6.1M -7.9M -8.0M -13.0M
Net income from continuing op. -6.6M -8.3M -8.5M -13.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 4 minutes

23:55
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).